Csam Health Group AS
F:6Q1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Csam Health Group AS
F:6Q1
|
NO |
|
Land Business Co Ltd
TSE:8944
|
JP |
|
C
|
China Jo-Jo Drugstores Holdings Inc
NASDAQ:CJJD
|
CN |
|
E
|
ELEVAI Labs Inc
NASDAQ:ELAB
|
US |
|
T
|
TechCreate Group Ltd
AMEX:TCGL
|
SG |
|
E
|
Egeplast Ege Plastik Ticaret ve Sanayi AS
IST:EPLAS.E
|
TR |
|
M
|
MHP Hotel AG
XMUN:CDZ0
|
DE |
|
Medibio Ltd
ASX:MEB
|
AU |
|
E
|
Easy Bio Inc
KOSDAQ:353810
|
KR |
|
D
|
Dollarama Inc
OTC:DLMAF
|
CA |
|
Kingwest Resources Ltd
ASX:KWR
|
AU |
|
U
|
Unifiedpost Group SA
XBRU:UPG
|
BE |
|
Beazley PLC
LSE:BEZ
|
UK |
Wall Street
Price Targets
6Q1 Price Targets Summary
Csam Health Group AS
According to Wall Street analysts, the average 1-year price target for
6Q1
is 5.43 EUR
with a low forecast of 5.38 EUR and a high forecast of 5.59 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is 6Q1's stock price target?
Price Target
5.43
EUR
According to Wall Street analysts, the average 1-year price target for
6Q1
is 5.43 EUR
with a low forecast of 5.38 EUR and a high forecast of 5.59 EUR.
What is Csam Health Group AS's Revenue forecast?
Projected CAGR
-66%
For the last 3 years the
compound annual growth rate for
Csam Health Group AS's revenue is
21%.
The projected
CAGR
for the next 2 years is
-66%.
